世界の糖尿病性神経障害性疼痛薬市場:販売動向2018

【英語タイトル】Global Diabetic Neuropathic Pain Drug Sales Market Report 2018

QYResearchが出版した調査資料(QYR8020494)・商品コード:QYR8020494
・発行会社(調査会社):QYResearch
・発行日:2018年1月16日
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポート(2018年版)では、糖尿病性神経障害性疼痛薬の世界市場について調査・分析し、糖尿病性神経障害性疼痛薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、糖尿病性神経障害性疼痛薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・糖尿病性神経障害性疼痛薬市場概要
・糖尿病性神経障害性疼痛薬のメーカー別販売量・メーカー別シェア
・糖尿病性神経障害性疼痛薬の世界市場:種類別販売量・市場シェア
・糖尿病性神経障害性疼痛薬の世界市場:用途別販売量・市場シェア
・糖尿病性神経障害性疼痛薬の世界市場:地域別販売量・市場シェア
・糖尿病性神経障害性疼痛薬のアメリカ市場規模
・糖尿病性神経障害性疼痛薬の中国市場規模
・糖尿病性神経障害性疼痛薬のヨーロッパ市場規模
・糖尿病性神経障害性疼痛薬の日本市場規模
・糖尿病性神経障害性疼痛薬の東南アジア市場規模
・糖尿病性神経障害性疼痛薬のインド市場規模
・糖尿病性神経障害性疼痛薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・糖尿病性神経障害性疼痛薬のコスト分析・価格動向
・糖尿病性神経障害性疼痛薬の産業チェーン(サプライチェーン分析)
・糖尿病性神経障害性疼痛薬のマーケティング戦略・販売チャネル、流通業者
・糖尿病性神経障害性疼痛薬市場への影響要因分析
・糖尿病性神経障害性疼痛薬の世界市場予測
・糖尿病性神経障害性疼痛薬のアメリカ市場予測
・糖尿病性神経障害性疼痛薬の中国市場予測
・糖尿病性神経障害性疼痛薬のヨーロッパ市場予測
・糖尿病性神経障害性疼痛薬の日本市場予測
・糖尿病性神経障害性疼痛薬の東南アジア市場予測
・糖尿病性神経障害性疼痛薬のインド市場予測
・糖尿病性神経障害性疼痛薬の種類別世界市場予測
・糖尿病性神経障害性疼痛薬の用途別世界市場予測
...
【レポートの概要】

In this report, the global Diabetic Neuropathic Pain Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Diabetic Neuropathic Pain Drug for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Diabetic Neuropathic Pain Drug market competition by top manufacturers/players, with Diabetic Neuropathic Pain Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Astellas Pharma Inc.
AstraZeneca Plc
BioDelivery Sciences International, Inc.
Boehringer Ingelheim GmbH
Daiichi Sankyo Company, Limited
Dong-A Socio Group
Eli Lilly and Company
Glenmark Pharmaceuticals Ltd.
Hydra Biosciences, Inc.
Immune Pharmaceuticals Inc.
Laboratorios Del Dr. Esteve S.A.
Lohocla Research Corporation
Mertiva AB
Novaremed
Pharmaleads
RAPID Pharmaceuticals AG
Relmada Therapeutics, Inc.
Sphaera Pharma Pvt. Ltd.
Theravasc, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
AZD-5213
Clonidine Hydrochloride
Duloxetine Hydrochloride DR
E-52862
Filgrastim
GERPOOI
GRC-17536
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Clinic
Hospital
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Diabetic Neuropathic Pain Drug Sales Market Report 2018
1 Diabetic Neuropathic Pain Drug Market Overview
1.1 Product Overview and Scope of Diabetic Neuropathic Pain Drug
1.2 Classification of Diabetic Neuropathic Pain Drug by Product Category
1.2.1 Global Diabetic Neuropathic Pain Drug Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Diabetic Neuropathic Pain Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 AZD-5213
1.2.4 Clonidine Hydrochloride
1.2.5 Duloxetine Hydrochloride DR
1.2.6 E-52862
1.2.7 Filgrastim
1.2.8 GERPOOI
1.2.9 GRC-17536
1.2.10 Others
1.3 Global Diabetic Neuropathic Pain Drug Market by Application/End Users
1.3.1 Global Diabetic Neuropathic Pain Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Diabetic Neuropathic Pain Drug Market by Region
1.4.1 Global Diabetic Neuropathic Pain Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Diabetic Neuropathic Pain Drug Status and Prospect (2013-2025)
1.4.3 China Diabetic Neuropathic Pain Drug Status and Prospect (2013-2025)
1.4.4 Europe Diabetic Neuropathic Pain Drug Status and Prospect (2013-2025)
1.4.5 Japan Diabetic Neuropathic Pain Drug Status and Prospect (2013-2025)
1.4.6 Southeast Asia Diabetic Neuropathic Pain Drug Status and Prospect (2013-2025)
1.4.7 India Diabetic Neuropathic Pain Drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Diabetic Neuropathic Pain Drug (2013-2025)
1.5.1 Global Diabetic Neuropathic Pain Drug Sales and Growth Rate (2013-2025)
1.5.2 Global Diabetic Neuropathic Pain Drug Revenue and Growth Rate (2013-2025)

2 Global Diabetic Neuropathic Pain Drug Competition by Players/Suppliers, Type and Application
2.1 Global Diabetic Neuropathic Pain Drug Market Competition by Players/Suppliers
2.1.1 Global Diabetic Neuropathic Pain Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Diabetic Neuropathic Pain Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Diabetic Neuropathic Pain Drug (Volume and Value) by Type
2.2.1 Global Diabetic Neuropathic Pain Drug Sales and Market Share by Type (2013-2018)
2.2.2 Global Diabetic Neuropathic Pain Drug Revenue and Market Share by Type (2013-2018)
2.3 Global Diabetic Neuropathic Pain Drug (Volume and Value) by Region
2.3.1 Global Diabetic Neuropathic Pain Drug Sales and Market Share by Region (2013-2018)
2.3.2 Global Diabetic Neuropathic Pain Drug Revenue and Market Share by Region (2013-2018)
2.4 Global Diabetic Neuropathic Pain Drug (Volume) by Application

3 United States Diabetic Neuropathic Pain Drug (Volume, Value and Sales Price)
3.1 United States Diabetic Neuropathic Pain Drug Sales and Value (2013-2018)
3.1.1 United States Diabetic Neuropathic Pain Drug Sales and Growth Rate (2013-2018)
3.1.2 United States Diabetic Neuropathic Pain Drug Revenue and Growth Rate (2013-2018)
3.1.3 United States Diabetic Neuropathic Pain Drug Sales Price Trend (2013-2018)
3.2 United States Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Application (2013-2018)

4 China Diabetic Neuropathic Pain Drug (Volume, Value and Sales Price)
4.1 China Diabetic Neuropathic Pain Drug Sales and Value (2013-2018)
4.1.1 China Diabetic Neuropathic Pain Drug Sales and Growth Rate (2013-2018)
4.1.2 China Diabetic Neuropathic Pain Drug Revenue and Growth Rate (2013-2018)
4.1.3 China Diabetic Neuropathic Pain Drug Sales Price Trend (2013-2018)
4.2 China Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Players (2013-2018)
4.3 China Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Type (2013-2018)
4.4 China Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Application (2013-2018)

5 Europe Diabetic Neuropathic Pain Drug (Volume, Value and Sales Price)
5.1 Europe Diabetic Neuropathic Pain Drug Sales and Value (2013-2018)
5.1.1 Europe Diabetic Neuropathic Pain Drug Sales and Growth Rate (2013-2018)
5.1.2 Europe Diabetic Neuropathic Pain Drug Revenue and Growth Rate (2013-2018)
5.1.3 Europe Diabetic Neuropathic Pain Drug Sales Price Trend (2013-2018)
5.2 Europe Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Players (2013-2018)
5.3 Europe Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Type (2013-2018)
5.4 Europe Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Application (2013-2018)

6 Japan Diabetic Neuropathic Pain Drug (Volume, Value and Sales Price)
6.1 Japan Diabetic Neuropathic Pain Drug Sales and Value (2013-2018)
6.1.1 Japan Diabetic Neuropathic Pain Drug Sales and Growth Rate (2013-2018)
6.1.2 Japan Diabetic Neuropathic Pain Drug Revenue and Growth Rate (2013-2018)
6.1.3 Japan Diabetic Neuropathic Pain Drug Sales Price Trend (2013-2018)
6.2 Japan Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Diabetic Neuropathic Pain Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Diabetic Neuropathic Pain Drug Sales and Value (2013-2018)
7.1.1 Southeast Asia Diabetic Neuropathic Pain Drug Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Diabetic Neuropathic Pain Drug Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Diabetic Neuropathic Pain Drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Application (2013-2018)

8 India Diabetic Neuropathic Pain Drug (Volume, Value and Sales Price)
8.1 India Diabetic Neuropathic Pain Drug Sales and Value (2013-2018)
8.1.1 India Diabetic Neuropathic Pain Drug Sales and Growth Rate (2013-2018)
8.1.2 India Diabetic Neuropathic Pain Drug Revenue and Growth Rate (2013-2018)
8.1.3 India Diabetic Neuropathic Pain Drug Sales Price Trend (2013-2018)
8.2 India Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Diabetic Neuropathic Pain Drug Sales Volume and Market Share by Application (2013-2018)

9 Global Diabetic Neuropathic Pain Drug Players/Suppliers Profiles and Sales Data
9.1 Astellas Pharma Inc.
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Diabetic Neuropathic Pain Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Astellas Pharma Inc. Diabetic Neuropathic Pain Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 AstraZeneca Plc
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Diabetic Neuropathic Pain Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 AstraZeneca Plc Diabetic Neuropathic Pain Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 BioDelivery Sciences International, Inc.
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Diabetic Neuropathic Pain Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 BioDelivery Sciences International, Inc. Diabetic Neuropathic Pain Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Boehringer Ingelheim GmbH
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Diabetic Neuropathic Pain Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Boehringer Ingelheim GmbH Diabetic Neuropathic Pain Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Daiichi Sankyo Company, Limited
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Diabetic Neuropathic Pain Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Daiichi Sankyo Company, Limited Diabetic Neuropathic Pain Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Dong-A Socio Group
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Diabetic Neuropathic Pain Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Dong-A Socio Group Diabetic Neuropathic Pain Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Eli Lilly and Company
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Diabetic Neuropathic Pain Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Eli Lilly and Company Diabetic Neuropathic Pain Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Glenmark Pharmaceuticals Ltd.
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Diabetic Neuropathic Pain Drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Glenmark Pharmaceuticals Ltd. Diabetic Neuropathic Pain Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Hydra Biosciences, Inc.
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Diabetic Neuropathic Pain Drug Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Hydra Biosciences, Inc. Diabetic Neuropathic Pain Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Immune Pharmaceuticals Inc.
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Diabetic Neuropathic Pain Drug Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Immune Pharmaceuticals Inc. Diabetic Neuropathic Pain Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Laboratorios Del Dr. Esteve S.A.
9.12 Lohocla Research Corporation
9.13 Mertiva AB
9.14 Novaremed
9.15 Pharmaleads
9.16 RAPID Pharmaceuticals AG
9.17 Relmada Therapeutics, Inc.
9.18 Sphaera Pharma Pvt. Ltd.
9.19 Theravasc, Inc.

10 Diabetic Neuropathic Pain Drug Maufacturing Cost Analysis
10.1 Diabetic Neuropathic Pain Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Diabetic Neuropathic Pain Drug
10.3 Manufacturing Process Analysis of Diabetic Neuropathic Pain Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Diabetic Neuropathic Pain Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Diabetic Neuropathic Pain Drug Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Diabetic Neuropathic Pain Drug Market Forecast (2018-2025)
14.1 Global Diabetic Neuropathic Pain Drug Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Diabetic Neuropathic Pain Drug Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Diabetic Neuropathic Pain Drug Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Diabetic Neuropathic Pain Drug Price and Trend Forecast (2018-2025)
14.2 Global Diabetic Neuropathic Pain Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Diabetic Neuropathic Pain Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Diabetic Neuropathic Pain Drug Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Diabetic Neuropathic Pain Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 China Diabetic Neuropathic Pain Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 Europe Diabetic Neuropathic Pain Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Diabetic Neuropathic Pain Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Diabetic Neuropathic Pain Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Diabetic Neuropathic Pain Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Diabetic Neuropathic Pain Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Diabetic Neuropathic Pain Drug Sales Forecast by Type (2018-2025)
14.3.2 Global Diabetic Neuropathic Pain Drug Revenue Forecast by Type (2018-2025)
14.3.3 Global Diabetic Neuropathic Pain Drug Price Forecast by Type (2018-2025)
14.4 Global Diabetic Neuropathic Pain Drug Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Diabetic Neuropathic Pain Drug
Figure Global Diabetic Neuropathic Pain Drug Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Diabetic Neuropathic Pain Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure AZD-5213 Product Picture
Figure Clonidine Hydrochloride Product Picture
Figure Duloxetine Hydrochloride DR Product Picture
Figure E-52862 Product Picture
Figure Filgrastim Product Picture
Figure GERPOOI Product Picture
Figure GRC-17536 Product Picture
Figure Others Product Picture
Figure Global Diabetic Neuropathic Pain Drug Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Diabetic Neuropathic Pain Drug by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Diabetic Neuropathic Pain Drug Market Size (Million USD) by Regions (2013-2025)
Figure United States Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) (2013-2018)
Table Global Diabetic Neuropathic Pain Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Diabetic Neuropathic Pain Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Diabetic Neuropathic Pain Drug Sales Share by Players/Suppliers
Figure 2017 Diabetic Neuropathic Pain Drug Sales Share by Players/Suppliers
Figure Global Diabetic Neuropathic Pain Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Diabetic Neuropathic Pain Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Diabetic Neuropathic Pain Drug Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Diabetic Neuropathic Pain Drug Revenue Share by Players
Table 2017 Global Diabetic Neuropathic Pain Drug Revenue Share by Players
Table Global Diabetic Neuropathic Pain Drug Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Diabetic Neuropathic Pain Drug Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Diabetic Neuropathic Pain Drug by Type (2013-2018)
Figure Global Diabetic Neuropathic Pain Drug Sales Growth Rate by Type (2013-2018)
Table Global Diabetic Neuropathic Pain Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Diabetic Neuropathic Pain Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Diabetic Neuropathic Pain Drug by Type (2013-2018)
Figure Global Diabetic Neuropathic Pain Drug Revenue Growth Rate by Type (2013-2018)
Table Global Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Diabetic Neuropathic Pain Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Diabetic Neuropathic Pain Drug by Region (2013-2018)
Figure Global Diabetic Neuropathic Pain Drug Sales Growth Rate by Region in 2017
Table Global Diabetic Neuropathic Pain Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Diabetic Neuropathic Pain Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Diabetic Neuropathic Pain Drug by Region (2013-2018)
Figure Global Diabetic Neuropathic Pain Drug Revenue Growth Rate by Region in 2017
Table Global Diabetic Neuropathic Pain Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Diabetic Neuropathic Pain Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Diabetic Neuropathic Pain Drug by Region (2013-2018)
Figure Global Diabetic Neuropathic Pain Drug Revenue Market Share by Region in 2017
Table Global Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Diabetic Neuropathic Pain Drug Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Diabetic Neuropathic Pain Drug by Application (2013-2018)
Figure Global Diabetic Neuropathic Pain Drug Sales Market Share by Application (2013-2018)
Figure United States Diabetic Neuropathic Pain Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Diabetic Neuropathic Pain Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Players (2013-2018)
Table United States Diabetic Neuropathic Pain Drug Sales Volume Market Share by Players (2013-2018)
Figure United States Diabetic Neuropathic Pain Drug Sales Volume Market Share by Players in 2017
Table United States Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Type (2013-2018)
Table United States Diabetic Neuropathic Pain Drug Sales Volume Market Share by Type (2013-2018)
Figure United States Diabetic Neuropathic Pain Drug Sales Volume Market Share by Type in 2017
Table United States Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Application (2013-2018)
Table United States Diabetic Neuropathic Pain Drug Sales Volume Market Share by Application (2013-2018)
Figure United States Diabetic Neuropathic Pain Drug Sales Volume Market Share by Application in 2017
Figure China Diabetic Neuropathic Pain Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Diabetic Neuropathic Pain Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table China Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Players (2013-2018)
Table China Diabetic Neuropathic Pain Drug Sales Volume Market Share by Players (2013-2018)
Figure China Diabetic Neuropathic Pain Drug Sales Volume Market Share by Players in 2017
Table China Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Type (2013-2018)
Table China Diabetic Neuropathic Pain Drug Sales Volume Market Share by Type (2013-2018)
Figure China Diabetic Neuropathic Pain Drug Sales Volume Market Share by Type in 2017
Table China Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Application (2013-2018)
Table China Diabetic Neuropathic Pain Drug Sales Volume Market Share by Application (2013-2018)
Figure China Diabetic Neuropathic Pain Drug Sales Volume Market Share by Application in 2017
Figure Europe Diabetic Neuropathic Pain Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Diabetic Neuropathic Pain Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Diabetic Neuropathic Pain Drug Sales Volume Market Share by Players (2013-2018)
Figure Europe Diabetic Neuropathic Pain Drug Sales Volume Market Share by Players in 2017
Table Europe Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Diabetic Neuropathic Pain Drug Sales Volume Market Share by Type (2013-2018)
Figure Europe Diabetic Neuropathic Pain Drug Sales Volume Market Share by Type in 2017
Table Europe Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Diabetic Neuropathic Pain Drug Sales Volume Market Share by Application (2013-2018)
Figure Europe Diabetic Neuropathic Pain Drug Sales Volume Market Share by Application in 2017
Figure Japan Diabetic Neuropathic Pain Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Diabetic Neuropathic Pain Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Diabetic Neuropathic Pain Drug Sales Volume Market Share by Players (2013-2018)
Figure Japan Diabetic Neuropathic Pain Drug Sales Volume Market Share by Players in 2017
Table Japan Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Diabetic Neuropathic Pain Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Diabetic Neuropathic Pain Drug Sales Volume Market Share by Type in 2017
Table Japan Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Diabetic Neuropathic Pain Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Diabetic Neuropathic Pain Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Diabetic Neuropathic Pain Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Diabetic Neuropathic Pain Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Diabetic Neuropathic Pain Drug Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Diabetic Neuropathic Pain Drug Sales Volume Market Share by Players in 2017
Table Southeast Asia Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Diabetic Neuropathic Pain Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Diabetic Neuropathic Pain Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Diabetic Neuropathic Pain Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Diabetic Neuropathic Pain Drug Sales Volume Market Share by Application in 2017
Figure India Diabetic Neuropathic Pain Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Diabetic Neuropathic Pain Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table India Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Players (2013-2018)
Table India Diabetic Neuropathic Pain Drug Sales Volume Market Share by Players (2013-2018)
Figure India Diabetic Neuropathic Pain Drug Sales Volume Market Share by Players in 2017
Table India Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Type (2013-2018)
Table India Diabetic Neuropathic Pain Drug Sales Volume Market Share by Type (2013-2018)
Figure India Diabetic Neuropathic Pain Drug Sales Volume Market Share by Type in 2017
Table India Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) by Application (2013-2018)
Table India Diabetic Neuropathic Pain Drug Sales Volume Market Share by Application (2013-2018)
Figure India Diabetic Neuropathic Pain Drug Sales Volume Market Share by Application in 2017
Table Astellas Pharma Inc. Basic Information List
Table Astellas Pharma Inc. Diabetic Neuropathic Pain Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Astellas Pharma Inc. Diabetic Neuropathic Pain Drug Sales Growth Rate (2013-2018)
Figure Astellas Pharma Inc. Diabetic Neuropathic Pain Drug Sales Global Market Share (2013-2018)
Figure Astellas Pharma Inc. Diabetic Neuropathic Pain Drug Revenue Global Market Share (2013-2018)
Table AstraZeneca Plc Basic Information List
Table AstraZeneca Plc Diabetic Neuropathic Pain Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AstraZeneca Plc Diabetic Neuropathic Pain Drug Sales Growth Rate (2013-2018)
Figure AstraZeneca Plc Diabetic Neuropathic Pain Drug Sales Global Market Share (2013-2018)
Figure AstraZeneca Plc Diabetic Neuropathic Pain Drug Revenue Global Market Share (2013-2018)
Table BioDelivery Sciences International, Inc. Basic Information List
Table BioDelivery Sciences International, Inc. Diabetic Neuropathic Pain Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure BioDelivery Sciences International, Inc. Diabetic Neuropathic Pain Drug Sales Growth Rate (2013-2018)
Figure BioDelivery Sciences International, Inc. Diabetic Neuropathic Pain Drug Sales Global Market Share (2013-2018
Figure BioDelivery Sciences International, Inc. Diabetic Neuropathic Pain Drug Revenue Global Market Share (2013-2018)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Diabetic Neuropathic Pain Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim GmbH Diabetic Neuropathic Pain Drug Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim GmbH Diabetic Neuropathic Pain Drug Sales Global Market Share (2013-2018)
Figure Boehringer Ingelheim GmbH Diabetic Neuropathic Pain Drug Revenue Global Market Share (2013-2018)
Table Daiichi Sankyo Company, Limited Basic Information List
Table Daiichi Sankyo Company, Limited Diabetic Neuropathic Pain Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Daiichi Sankyo Company, Limited Diabetic Neuropathic Pain Drug Sales Growth Rate (2013-2018)
Figure Daiichi Sankyo Company, Limited Diabetic Neuropathic Pain Drug Sales Global Market Share (2013-2018)
Figure Daiichi Sankyo Company, Limited Diabetic Neuropathic Pain Drug Revenue Global Market Share (2013-2018)
Table Dong-A Socio Group Basic Information List
Table Dong-A Socio Group Diabetic Neuropathic Pain Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Dong-A Socio Group Diabetic Neuropathic Pain Drug Sales Growth Rate (2013-2018)
Figure Dong-A Socio Group Diabetic Neuropathic Pain Drug Sales Global Market Share (2013-2018
Figure Dong-A Socio Group Diabetic Neuropathic Pain Drug Revenue Global Market Share (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Diabetic Neuropathic Pain Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Diabetic Neuropathic Pain Drug Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Diabetic Neuropathic Pain Drug Sales Global Market Share (2013-2018)
Figure Eli Lilly and Company Diabetic Neuropathic Pain Drug Revenue Global Market Share (2013-2018)
Table Glenmark Pharmaceuticals Ltd. Basic Information List
Table Glenmark Pharmaceuticals Ltd. Diabetic Neuropathic Pain Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Glenmark Pharmaceuticals Ltd. Diabetic Neuropathic Pain Drug Sales Growth Rate (2013-2018)
Figure Glenmark Pharmaceuticals Ltd. Diabetic Neuropathic Pain Drug Sales Global Market Share (2013-2018
Figure Glenmark Pharmaceuticals Ltd. Diabetic Neuropathic Pain Drug Revenue Global Market Share (2013-2018)
Table Hydra Biosciences, Inc. Basic Information List
Table Hydra Biosciences, Inc. Diabetic Neuropathic Pain Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Hydra Biosciences, Inc. Diabetic Neuropathic Pain Drug Sales Growth Rate (2013-2018)
Figure Hydra Biosciences, Inc. Diabetic Neuropathic Pain Drug Sales Global Market Share (2013-2018)
Figure Hydra Biosciences, Inc. Diabetic Neuropathic Pain Drug Revenue Global Market Share (2013-2018)
Table Immune Pharmaceuticals Inc. Basic Information List
Table Immune Pharmaceuticals Inc. Diabetic Neuropathic Pain Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Immune Pharmaceuticals Inc. Diabetic Neuropathic Pain Drug Sales Growth Rate (2013-2018)
Figure Immune Pharmaceuticals Inc. Diabetic Neuropathic Pain Drug Sales Global Market Share (2013-2018)
Figure Immune Pharmaceuticals Inc. Diabetic Neuropathic Pain Drug Revenue Global Market Share (2013-2018)
Table Laboratorios Del Dr. Esteve S.A. Basic Information List
Table Lohocla Research Corporation Basic Information List
Table Mertiva AB Basic Information List
Table Novaremed Basic Information List
Table Pharmaleads Basic Information List
Table RAPID Pharmaceuticals AG Basic Information List
Table Relmada Therapeutics, Inc. Basic Information List
Table Sphaera Pharma Pvt. Ltd. Basic Information List
Table Theravasc, Inc. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Diabetic Neuropathic Pain Drug
Figure Manufacturing Process Analysis of Diabetic Neuropathic Pain Drug
Figure Diabetic Neuropathic Pain Drug Industrial Chain Analysis
Table Raw Materials Sources of Diabetic Neuropathic Pain Drug Major Players in 2017
Table Major Buyers of Diabetic Neuropathic Pain Drug
Table Distributors/Traders List
Figure Global Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Diabetic Neuropathic Pain Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Diabetic Neuropathic Pain Drug Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Diabetic Neuropathic Pain Drug Sales Volume Market Share Forecast by Regions in 2025
Table Global Diabetic Neuropathic Pain Drug Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Diabetic Neuropathic Pain Drug Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Diabetic Neuropathic Pain Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Diabetic Neuropathic Pain Drug Revenue and Growth Rate Forecast (2018-2025)
Figure Europe Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Diabetic Neuropathic Pain Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Diabetic Neuropathic Pain Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Diabetic Neuropathic Pain Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Diabetic Neuropathic Pain Drug Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Diabetic Neuropathic Pain Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Diabetic Neuropathic Pain Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Diabetic Neuropathic Pain Drug Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Diabetic Neuropathic Pain Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Diabetic Neuropathic Pain Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

糖尿病性神経障害性疼痛薬

★調査レポート[世界の糖尿病性神経障害性疼痛薬市場:販売動向2018] (コード:QYR8020494)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の糖尿病性神経障害性疼痛薬市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆